EBETAXEL

This brand name is authorized in Austria, Hong Kong SAR China, Israel, Singapore, South Africa, Tunisia, Turkey.

Active ingredients

The drug EBETAXEL contains one active pharmaceutical ingredient (API):

1	Paclitaxel UNII P88XT4IS4D - PACLITAXEL
	Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability results in the inhibition of the normal dynamic reorganisation of the microtubule network that is essential for vital interphase and mitotic cellular functions.
	Read more about Paclitaxel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EBETAXEL Concentrate for solution for infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01CD01	Paclitaxel	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	54588
IL	מִשְׂרַד הַבְּרִיאוּת	6131, 7928, 7929
SG	Health Sciences Authority	13701P
TN	Direction de la Pharmacie et du Médicament	6943121H, 6943131H, 6943132H, 6943133H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699205760080, 8699205760097, 8699205760103, 8699510760140, 8699510760164, 8699516765057, 8699516765064, 8699516765088
ZA	Health Products Regulatory Authority	A40/26/0544, A40/26/0545, A40/26/0546, A40/26/0547